Diagnostic procedures and treatment of patients with Myelodysplastic Syndromes (MDS) of low and intermediate-1 risk. Results of the outpatient MDS registry

被引：0
|
作者：
Schmitz, S.
Boettger, I
Schnell, R. [1 ]
Lerchenmueller, C. [2 ]
Sauer, A. [3 ]
Severin, K.
Germing, U. [4 ]
Steinmetz, H. T.
机构：
[1] Pioh Praxis Internist Onkol & Hamatol, Frechen, Germany
[2] Gemeinschaftspraxis Hamatol & Onkol G, Munster, Germany
[3] MVZ Hamatol Onkol, Potsdam, Germany
[4] Univ Dusseldorf, D-40225 Dusseldorf, Germany
来源：
ONKOLOGIE | 2012年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：148 / 148
页数：1
相关论文
共 50 条
  • [1] Diagnostic procedures and treatment of patients with Myelodysplastic Syndromes (MDS) in outpatient clinics - results of the outpatient MDS registry
    Schmitz, S.
    Boettger, I
    Welslau, M.
    Lerchenmueller, C.
    Sauer, A.
    Germing, U.
    [J]. ONKOLOGIE, 2011, 34 : 289 - 289
  • [2] Diagnostic procedures and treatment of patients with myelodysplastic syndromes (MDS) in outpatient clinics. Results of the outpatient MDS registry
    Schmitz, S.
    Boettger, I.
    Schnell, R.
    Sauer, A.
    Linde, H.
    Severin, K.
    Germing, U.
    Steinmetz, T.
    [J]. LEUKEMIA RESEARCH, 2013, 37 : S115 - S115
  • [3] Diagnostic procedures and treatment of patients with Myelodysplastic Syndromes (MDS) - update of the outpatient MDS registry
    Schmitz, S.
    Boettger, I
    Sauer, A.
    Buschmann, D.
    Germing, U.
    Severin, K.
    Steinmetz, H. T.
    [J]. ONKOLOGIE, 2013, 36 : 242 - 242
  • [4] Disease-Management of Low- and Intermediate-1 Risk Myelodysplastic Syndromes: Report on 800 Newly Diagnosed MDS Patients From the European LeukemiaNet MDS Registry
    de Swart, Louise
    Smith, Alex
    Fenaux, Pierre
    Symeonidis, Argyris
    Hellstrom-Lindberg, Eva
    Sanz, Guillermo
    Cermak, Jaroslav
    Georgescu, Otilia
    Germing, Ulrich
    MacKenzie, Marius
    Beyne-Rauzy, Odile
    Malcovati, Luca
    Stauder, Reinhard
    Droste, Jackie
    Bowen, David
    de Witte, Theo
    [J]. BLOOD, 2010, 116 (21) : 1201 - 1202
  • [5] Need of transfusions, treatment and survival of patients with Myelodysplastic Syndromes (MDS): Update of the outpatient MDS registry
    Steinmetz, H. T.
    Boettger, I
    Lathan, B.
    Sauer, A.
    Severin, K.
    Germing, U.
    Schmitz, S.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 234 - 234
  • [6] LUSPATERCEPT INCREASES HEMOGLOBIN AND REDUCES TRANSFUSION BURDEN IN PATIENTS WITH LOW OR INTERMEDIATE-1 RISK MYELODYSPLASTIC SYNDROMES (MDS): PRELIMINARY RESULTS FROM THE PHASE 2 PACE-MDS STUDY
    Platzbecker, U.
    Germing, U.
    Giagounidis, A.
    Goetze, K.
    Kiewe, P.
    Mayer, K.
    Ottmann, O.
    Radsak, M.
    Wolff, T.
    Haase, D.
    Hankin, M.
    Wilson, D.
    Zhang, X.
    Laadem, A.
    Sherman, M.
    Attie, K.
    [J]. HAEMATOLOGICA, 2015, 100 : 192 - 192
  • [7] Biomarkers of Ineffective Erythropoiesis Predict Response to Luspatercept in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS): Final Results from the Phase 2 PACE-MDS Study
    Platzbecker, Uwe
    Germing, Ulrich
    Giagounidis, Aristoteles
    Goetze, Katharina
    Kiewe, Philipp
    Mayer, Karin Tina
    Ottmann, Oliver
    Radsak, Markus
    Wolff, Thomas
    Haase, Detlef
    Hankin, Monty
    Wilson, Dawn
    Zhang, Xiaosha
    Laadem, Abderrahmane
    Sherman, Matthew L.
    Attie, Kenneth M.
    [J]. BLOOD, 2015, 126 (23)
  • [8] Treatment Outcome of Patients with Myelodysplastic Syndromes (MDS) in Regular Care: Incidence of IPSS Risk Groups and Different Therapies in the German Outpatient MDS Registry
    Steinmetz, H. Tilman
    Boettger, Isolde
    Lathan, Bernd
    Sauer, Annette
    Moorahrend, Enno
    Severin, Kai
    Germing, Ulrich
    Schmitz, Stephan
    Gattermann, Norbert
    [J]. BLOOD, 2014, 124 (21)
  • [9] ACE-536 INCREASES HEMOGLOBIN LEVELS IN PATIENTS WITH LOW OR INTERMEDIATE-1 RISK MYELODYSPLASTIC SYNDROMES (MDS): PRELIMINARY RESULTS FROM A PHASE 2 STUDY
    Platzbecker, U.
    Germing, U.
    Giagounidis, A.
    Goetze, K.
    Kiewe, P.
    Mayer, K.
    Ottmann, O.
    Radsak, M.
    Wolff, T.
    Hankin, M.
    Wilson, D.
    Sherman, M.
    Attie, K.
    [J]. HAEMATOLOGICA, 2014, 99 : 500 - 500
  • [10] LUSPATERCEPT INCREASES HEMOGLOBIN AND REDUCES TRANSFUSION BURDEN IN PATIENTS WITH LOW OR INTERMEDIATE-1 RISK MYELODYSPLASTIC SYNDROMES (MDS): PRELIMINARY RESULTS FROM A PHASE 2 STUDY
    Platzbecker, U.
    Germing, U.
    Giagounidis, A.
    Goetze, K.
    Kiewe, P.
    Mayer, K.
    Ottmann, O.
    Radsak, M.
    Wolff, T.
    Haase, D.
    Hankin, M.
    Wilson, D.
    Zhang, X.
    Laadem, A.
    Sherman, M.
    Attie, K.
    [J]. LEUKEMIA RESEARCH, 2015, 39 : S25 - S25
12345